MDT monthly performance report
View MDT's monthly returns, drawdown, and seasonality trends — updated every month.
MDT monthly report
—
Key takeaways
- Medtronic (MDT) closed November 2026 at $102.86, up 6.55% for the month and +6.99% over the trailing 12 months.
- Year-to-date, MDT is +7.08%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +16.39% versus its 200-day moving average ($88.38), a bullish technical signal.
- Over the past three years, MDT has underperformed the S&P 500 by −28.67%, with a relative strength index reading of 83.3.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Medtronic ended November 2026 at $102.86, posting a monthly return of +6.55%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +6.73%.
The current quarter stands at +19.20% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +16.39% versus the 200-day moving average ($88.38).
Year-to-date, MDT is +7.08% against SPY +10.62%, a gap of −3.55%. The stock is currently −3.26% below its 52-week high, with maximum 3-year drawdown at −30.00%.
| Period | MDT | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.85% | −0.36% | +2.21% |
| 1 Week | +1.04% | +2.59% | −1.55% |
| 1 Month | +6.55% | −0.18% | +6.73% |
| 3 Months | +13.53% | −2.37% | +15.90% |
| 6 Months | +33.64% | +0.83% | +32.81% |
| YTD | +7.08% | +10.62% | −3.55% |
| 12 Months | +6.99% | +12.25% | −5.26% |
| 3 Years | +42.70% | +71.37% | −28.67% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2025 | +16.13% |
| #2 | Jan 2025 | +13.70% |
| #3 | Nov 2023 | +12.34% |
| #4 | Oct 2026 | +11.88% |
| #5 | Aug 2024 | +10.28% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −11.27% |
| #2 | Oct 2023 | −9.95% |
| #3 | May 2026 | −8.84% |
| #4 | Dec 2025 | −8.80% |
| #5 | Apr 2024 | −7.93% |
| Quarter | Return |
|---|---|
| Q3 2025 | +9.26% |
| Q4 2025 | +0.86% |
| Q1 2026 | −9.80% |
| Q2 2026 | −9.72% |
| Q3 2026 | +10.30% |
| Q4 2026 (QTD) | +19.20% |
| Year | Return |
|---|---|
| 2023 | +6.00% |
| 2024 | −3.03% |
| 2025 | +20.26% |
| 2026 | +7.08% |
| Metric | Value |
|---|---|
| 52-Week High | $106.33 (2025-11-26) |
| 52-Week Low | $73.32 (2026-06-02) |
| Current Price | $102.86 |
| 200-Day Moving Average | $88.38 |
| Price vs 200DMA | +16.39% |
| 3-Year Maximum Drawdown | −30.00% (2026-06-02) |
| Current Drawdown from 52W High | −3.26% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 83.3 |
| 3-Year Excess Return vs S&P 500 | −28.67% |
| RS Peak | 112 (Jan 2024) |
| RS Trough | 59.3 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MDT's return for this report period?
MDT returned +6.55% in the latest monthly window ending 2026-11-13.
Has MDT outperformed SPY year to date?
YTD MDT: +7.08% vs SPY: +10.62%.
What is MDT's 12-month return?
+6.99% over the trailing 12 months.
Is MDT above or below its 200-day moving average?
Price is +16.39% versus 200DMA ($88.38).
What is the maximum drawdown in the 3-year window?
−30.00% on 2026-06-02.